Ken Griffin Stock Portfolio: Top 5 Stock Picks

2. Boston Scientific Corporation (NYSE:BSX)

Citadel Investment’s Q3 2023 Investment: $1.1 billion

Boston Scientific Corporation (NYSE:BSX) is a healthcare company that makes and sells medical devices used by heart patients. Like several other firms on our list, it has also beaten analyst EPS estimates in all four of its latest quarter, and the shares are also rated Strong Buy on average with an average share price target of $60.48.

Insider Monkey’s second quarter of 2023 survey covering 910 hedge funds revealed that 69 had invested in Boston Scientific Corporation (NYSE:BSX). During the third quarter, Ken Griffin’s Citadel Investment Group was the biggest shareholder, owning 21 million shares that are worth $1.1 billion.

Follow Boston Scientific Corp (NYSE:BSX)